Skip to main content

Biohaven Ltd.

BHVN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001935979

No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 297 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Biohaven Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Biohaven Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Biohaven Ltd.
NameTitleLast reported holdingLast filingFilings, past year
Gentile KimberlySVP, Clinical Operations99,557Sep 17, 20263
Childs John WDirector2,323,971IndirectApr 30, 20263
Gregory Julia PDirector25,665Apr 30, 20261
Hugin Robert JDirector12,959Apr 30, 20261
Bailey GregoryDirector2,020,071Apr 30, 20262
Heffernan Michael ThomasDirector15,178Apr 30, 20261
Mehta KishanDirector17,342IndirectApr 30, 20262
Antonijevic IrinaDirector2,535Apr 30, 20261
Coric VladChief Executive Officer1,803,968Mar 3, 20263
Car BruceChief Scientific Officer7,715Mar 3, 20262
Clark George C.VP, Chief Accounting Officer66,978Mar 3, 20263
Buten MatthewChief Financial Officer195,652Mar 3, 20262
Biohaven Pharmaceutical Holding Co Ltd.10% Owner0Oct 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 9, 2026 (view filing)Mar 4, 2025370 daysChilds John WDirectorPPurchase+28.4K$30.43+$864.2K+1.2%2.32M afterAmended
Nov 18, 2025 (view filing)Nov 171 dayClark George C.VP, Chief Accounting OfficerPPurchase+17.0K$8.52+$144.8K+566.7%20.0K after
Nov 17, 2025 (view filing)Nov 134 daysBailey GregoryDirectorPPurchase+400.0K$7.50+$3.00M+24.7%2.02M after
Nov 17, 2025 (view filing)Nov 134 daysCoric VladChief Executive OfficerPPurchase+666.7K$7.50+$5.00M+902.4%740.5K after2 lots
Nov 17, 2025 (view filing)Nov 134 daysChilds John WDirectorPPurchase+3.33M$7.50+$25.0M+143.6%5.65M after
Mar 5, 2025 (view filing)Apr 22, 2024317 daysChilds John WDirectorPPurchase+73.2K$41.00+$3.00MNew position73.2K afterAmended
Dec 31, 2024 (view filing)Dec 301 dayChilds John WDirectorPPurchase+29.0K$35.94+$1.04M+1.2%2.37M after
Oct 3, 2024 (view filing)Oct 21 dayChilds John WDirectorPPurchase+21.1K$47.50+$1.00MNew position21.1K after
Oct 3, 2024 (view filing)Oct 21 dayCoric VladChief Executive OfficerPPurchase+21.1K$47.50+$1.00M+2.5%861.9K after
Sep 25, 2024 (view filing)Sep 241 dayBailey GregoryDirectorPPurchase+5.00K$44.19+$220.9K+0.3%1.62M after
Jul 19, 2024 (view filing)Jul 181 dayChilds John WDirectorPPurchase+28.4K$35.67+$1.01M+1.2%2.34M after
Jun 20, 2024 (view filing)Jun 173 daysCar BruceChief Scientific OfficerPPurchase+30.0K$33.58+$1.01MNew position30.0K after
May 31, 2024 (view filing)May 301 dayChilds John WDirectorPPurchase+28.0K$35.58+$996.2K+1.2%2.31M after
May 15, 2024 (view filing)May 132 daysBailey GregoryDirectorPPurchase+15.0K$34.19+$512.9K+0.9%1.62M after
May 14, 2024 (view filing)May 131 dayChilds John WDirectorPPurchase+28.5K$35.17+$1.00M+1.3%2.28M after
Apr 25, 2024 (view filing)Apr 241 dayBailey GregoryDirectorPPurchase+25.5K$39.18+$999.2K+1.6%1.60M after
Apr 23, 2024 (view filing)Apr 221 dayBailey GregoryDirectorPPurchase+48.8K$41.00+$2.00M+3.2%1.57M after
Apr 23, 2024 (view filing)Apr 221 dayCoric VladChief Executive OfficerPPurchase+122.0K$41.00+$5.00M+7.3%1.79M after
Dec 29, 2023 (view filing)Dec 29Same dayAntonijevic IrinaDirectorSSale−11.0K$41.79−$459.7K−81.3%2.54K after
Oct 10, 2023 (view filing)Oct 55 daysChilds John WDirectorPPurchase+454.5K$22.00+$10.0M+27.4%2.11M after2 lots
Oct 10, 2023 (view filing)Oct 55 daysCoric VladChief Executive OfficerPPurchaseCommon Share+340.9K$22.00+$7.50M+69.3%833.1K after
Oct 10, 2023 (view filing)Oct 55 daysCoric VladChief Executive OfficerPPurchase+113.6K$22.00+$2.50M+7.4%1.66M after
Oct 6, 2023 (view filing)Oct 51 dayButen MatthewChief Financial OfficerPPurchase+22.7K$22.00+$500.0K+13.6%189.4K after
Oct 6, 2023 (view filing)Oct 42 daysBailey GregoryDirectorPPurchase+17.8K$22.57+$402.1K+1.2%1.53M after
Aug 31, 2023 (view filing)Aug 301 dayChilds John WDirectorPPurchase+50.0K$18.44+$922.0K+2.6%1.98M after
Aug 7, 2023 (view filing)Aug 43 daysChilds John WDirectorPPurchase+100.0K$19.78+$1.98M+5.5%1.93M after
Mar 22, 2023 (view filing)Oct 25, 2022148 daysChilds John WDirectorPPurchase+3.71M$10.50+$39.0MNew position1.83M afterAmended2 lots
Nov 1, 2022 (view filing)Oct 311 dayCoric VladChief Executive OfficerPPurchase+25.8K$15.97+$412.0K+1.7%1.54M after
Oct 31, 2022 (view filing)Oct 283 daysCoric VladChief Executive OfficerPPurchase+41.9K$14.87+$623.5K+2.8%1.52M after
Oct 31, 2022 (view filing)Oct 283 daysCoric VladChief Executive OfficerPPurchase+100.0K$14.82+$1.48M+1,045.5%109.6K after
Oct 26, 2022 (view filing)Oct 251 dayGregory Julia PDirectorPPurchase+9.52K$10.50+$100.0K+59.0%25.7K after
Oct 26, 2022 (view filing)Oct 251 dayBailey GregoryDirectorPPurchase+200.0K$10.50+$2.10M+15.3%1.51M after
Oct 26, 2022 (view filing)Oct 251 dayButen MatthewChief Financial OfficerPPurchase+142.9K$10.50+$1.50M+600.3%166.7K after
Oct 26, 2022 (view filing)Oct 251 dayCoric VladChief Executive OfficerPPurchase+853.4K$10.50+$8.96M+137.1%1.48M after
Oct 6, 2022 (view filing)Oct 51 dayCoric VladChief Executive OfficerPPurchase+485.8K$10.31+$5.01MNew position399.4K after9 lots
Oct 5, 2022 (view filing)Oct 5Same dayChilds John WDirectorPPurchase+274.1K$8.98+$2.46M+18.1%1.79M after2 lots